Human Immunoglobulin G (IgG) Intravenous
Human Immunoglobulin G (IgG) Intravenous (IVIG) is a pooled blood fraction from human plasma containing primarily IgG antibodies. It is used therapeutically for immune deficiencies and autoimmune disorders. This product is a blood fraction prepared for therapeutic use, falling under tariff item 3002.12.00.
Import Duty Rates by Country of Origin
| Origin Country | MFN Tariff | Surtaxes | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇺🇸United States | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If the product is combined with other therapeutic components
Combination products may be classified under a different tariff item in heading 30.02.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right tariff item — and can price the duty on it in the same conversation.
Import Tips & Compliance
• Obtain a Canadian Drug Identification Number (DIN) from Health Canada prior to importation
• Ensure the product is shipped under proper cold chain conditions and provide temperature logs to the CBSA
• Submit a completed Form RC34 (Canada Customs Invoice) with the shipment
Related Products under Tariff item 3002.12.00
Botulism Antitoxin (Trivalent, Equine)
Botulism Antitoxin (Trivalent, Equine) is an antiserum derived from equine plasma that neutralizes botulinum neurotoxins A, B, and E. It is used therapeutically to treat botulism poisoning and is presented in sterile, injectable form. This product falls under tariff item 3002.12.00 as an antiserum prepared for therapeutic uses.
Cryoprecipitated Antihemophilic Factor from Human Plasma
Cryoprecipitated Antihemophilic Factor from Human Plasma is a human plasma fraction rich in factor VIII, fibrinogen, and von Willebrand factor. It is prepared by thawing frozen plasma at 1-6°C and is used to treat hemophilia A and fibrinogen deficiencies. This product is a blood fraction prepared for therapeutic use, classified under tariff item 3002.12.00.
Cytomegalovirus Immune Globulin Intravenous (CMV-IGIV)
Cytomegalovirus Immune Globulin Intravenous (CMV-IGIV) is a purified immunoglobulin fraction derived from human plasma of donors with high CMV antibody titers. It is used prophylactically in transplant patients to prevent CMV infection. This product is a blood fraction prepared for therapeutic or prophylactic use, falling under tariff item 3002.12.00.
Diphtheria Antitoxin (Equine)
Diphtheria Antitoxin (Equine) is an antiserum derived from equine plasma containing antibodies to diphtheria toxin. It is used for treating severe cases of diphtheria unresponsive to antibiotics. This product is an antiserum prepared for therapeutic use, classified under tariff item 3002.12.00.
Fresh Frozen Human Plasma
Fresh Frozen Human Plasma is obtained from whole human blood and frozen within 8 hours of collection to preserve clotting factors. It is used therapeutically for patients with coagulopathies or massive transfusion needs. This product is a blood fraction prepared for therapeutic use, falling under tariff item 3002.12.00.
Hepatitis B Immune Globulin (HBIG)
Hepatitis B Immune Globulin (HBIG) is a human plasma-derived blood fraction rich in antibodies to hepatitis B surface antigen. It is used for post-exposure prophylaxis against hepatitis B. This product is an antiserum prepared for therapeutic and prophylactic applications, falling under tariff item 3002.12.00.